Insinase features selective kinase response modulators (SKRMs) designed to support healthy cellular insulin function.
- Proprietary formula featuring SKRMs—RIAA and acacia—which have been shown to modulate insulin function†
- SKRMs modulate kinase signaling in adipocytes, which are fat-storing cells involved in glucose utilization and insulin signaling†
- In vitro and in vivo testing demonstrated inhibition of IL-6 cytokines—which influence insulin function†
†Based on in vitro and in vivo testing conducted at Functional Medicine Research Center, the clinical research arm of Metagenics.